跳至主要内容
临床试验/KCT0002300
KCT0002300招募中未知

Study on Clinical Effectiveness and Safety of Chuna Manual Therapy Combined with Acupuncture and Cupping for Frozen Shoulder(Adhesive Capsulitis); a multicenter, randomized, patient-assessor blind, clinical trial

Wonkwang University, Gwangju Medical Center0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
25(Year) 至 65(Year)(—)
性别
All

入选标准

  • 1) Males and females aged 25 to 65 years old, one side-shoulder pain for 6 weeks to 12 months, with a significant pain of visual analogue scale(VAS) 50mm-100mm, with more than 25% limitation of motion of range in two or more movements compared to the unilateral side, who can be diagnosed as frozen shoulder (adhesion capsulitis) by excluding simple fracture, dislocation, degenerative arthropathy, and calcific tendinitis in plain radiography.
  • 2) Those who have minimal help with the nature of the pain and are able to communicate sufficiently with the researcher and write a questionnaire.
  • 3) Those who have pledged not to receive treatment other than the prescribed treatment within the period of study.
  • 4) Agreed with written informed consent voluntarily.

排除标准

  • 1) History of major shoulder injury or surgery
  • 2) Patients with disorders of the cervical spine or other upper extremity that has a significant impact on the shoulder
  • 3) Patients who complain of shoulder pain accompanied by stroke, spinal cord injury, or other surgery
  • 4) Patients with fracture, dislocation, degenerative arthropathy and calcific tendinitis of the shoulder in plain radiography
  • 5) Patients with positive findings in physical examination(drop arm test, empty can test) for exclusion of rotator cuff tear
  • 6) ALT(SGPT), AST (SGOT) measured at a screening visit is greater than twice the normal upper limit (ULN)
  • 7) Serum creatinine and BUN (blood urea nitrogen) measured at a screening visit is greater than twice the normal upper limit (ULN)
  • 8) Patients with concomitant disorders contraindicated to Acetaminophen or hypersensitivity to Acetaminophen(Acetaminophen is relief medication in this study)
  • 9) Pregnant or breastfeeding patients
  • 10) Patients who are taking medicines after being diagnosed with mental disorders
  • 11) Patients with all other joint diseases that are associated with musculoskeletal disorders that may affect efficacy assessment, or that are considered to be unacceptable for this trial (eg. septic arthritis, inflammatory joint disease, gout, recurrent pseudogout, Paget's disease, joint fracture, exogenous ochronosis, acromegaly, hematochromatosis, Wilson's disease, primary osteochondrosis, hereditary disorder(eg. hyperkinetic), collagen gene abnormality, etc.)
  • 12) Patients who were considered as unsuitable for participation by the researcher

研究者

发起方
Wonkwang University, Gwangju Medical Center

相似试验